Universal Diagnostics S.A.

Universal Diagnostics S.A. company information, Employees & Contact Information

Universal Diagnostics S.A. (UDX) is a Spanish in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early. The UDX diagnostic platform is designed to detect various cancer types, e.g. colorectal, prostate, liver, pancreatic lung, breast cancer (>50% of all new cancer cases p.a.) via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected as part of a routine check-up, can be processed at a reference laboratory or hospital using standard equipment and then uploaded to the UDX Cloud for final algorithmic analysis. UDX’s first marker panel is a colorectal cancer screening test. The test identifies individuals who need to be referred for colonoscopy. Colorectal cancer is the 3rd most frequent cancer and 2nd deadliest cancer worldwide. The challenge is that colorectal cancer is mostly detected in late stages, with significantly decreased survival rates (11% survival rate in stage IV vs. 85% survival rate in stage I). To develop the test and execute its R&D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the globe.

Company Details

Employees
126
Founded
-
Address
Avenida Diego Martínez Barrio, 10, Edificio Insur 3ª Planta. Mod. 15,spain
Industry
Biotechnology
HQ
Sevilla, Andalucía
Looking for a particular Universal Diagnostics S.A. employee's phone or email?

Universal Diagnostics S.a. Questions

News

Universal DX Initiates Clinical Trial for FDA Approval of Signal-C® Colorectal Cancer Screening Blood Test - Business Wire

Universal DX Initiates Clinical Trial for FDA Approval of Signal-C® Colorectal Cancer Screening Blood Test Business Wire

Cancer diagnostics company that's raised tens of millions lands at Dallas' Pegasus Park - The Business Journals

Cancer diagnostics company that's raised tens of millions lands at Dallas' Pegasus Park The Business Journals

Universal DX secures €20 million loan from EIB to advance early cancer detection - EU-Startups

Universal DX secures €20 million loan from EIB to advance early cancer detection EU-Startups

Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States - PR Newswire

Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States PR Newswire

Universal DX secures funding to advance Signal-C blood test trial - Medical Device Network

Universal DX secures funding to advance Signal-C blood test trial Medical Device Network

Top Universal Diagnostics S.A. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant